“The Pink Sheet” DAILY is a comprehensive online information service assembled around-the-clock by the largest, most experienced, and well-connected news team in the pharmaceutical and biotechnology industries.
“The Pink Sheet” DAILY gives you more daily stories with greater detail and original analysis on pharmaceutical and biotechnology products, FDA actions, reimbursement issues, legislative developments, and other events shaping the industry landscape. “The Pink Sheet” DAILY stories are unique, not reprinted from “The Pink Sheet.” Join other successful executives and enjoy a competitive advantage by understanding daily financial, regulatory, and legal developments.
Our thorough, accurate, up-to-the-minute coverage includes:
- Corporate mergers and acquisitions, alliances, and licensing deals
- New drug trials, submissions, and launches
- FDA product approvals, enforcement actions, and warning letters
- Patent expirations and generic launches
- Research and manufacturing updates
- Marketing and advertising campaigns
- Investor calls
- Exclusive executive interviews
Your subscription to “The Pink Sheet” DAILY will include:
- ThePinkSheetDaily.com: Comprehensive, first-hand coverage of industry news and events plus in-depth stories and executive interviews
- Email Updates: Daily news delivered every morning to your inbox
- Online Access: Searchable access to a rolling 90 or 365 day archive
- Online Resources: Daily briefings and real-time headlines from a variety of news sources plus corporate announcements and select events
- Archives: Full access to the information you need from our searchable archives
- Topical RSS Feeds
Subscription Terms
Subscription Options
Buy Now
Includes:
Email newsletter with latest headlines, breaking news alerts, and access to “The Pink Sheet” DAILY — daily, in-depth analysis of the key developments shaping the biopharma industry.
Multiple users/site features: Contact Deanna Flanick at +1-908-547-2141 or D.Flanick@Elsevier.com.